PRG

0.00%

$1.22 prl global ltd

New Joint Venture, page-5

First 5 Last

Share
Profile

Follow
Nightmarez3k

6,201 Posts.

251

10/07/17

21:04

Post #: 25778004
Share

Originally posted by madamswer ↑

Just like the previous owner of this marine services business, namely Skilled Group, bought this marine business right at the very top of the cycle [*], one can be forgiven for feeling like PRG is now selling it at the bottom of the cycle.

([*] I recall SKE paying something like $80m for the business that PRG is now selling for an effective valuation of $59m (that's the Australia and New Zealand business), plus PRG is throwing in an international business (whatever that happens to be worth) for free.)

So many boards lack long-term vision; time and time again, they seem to get caught up in whatever the prevailing market mood happens to be. As a result, they invariably end up Buying-High and Selling-Low.

On a less gloomy note, I am sure the business being divested is not making any money at the moment and, as PRG still has a significant chunk of debt, following the SKE acquisition ($200m of it, with Net Det-to-EBITDA >2x and EBIT-to-Net Interest Cover of just 3.8x), any opportunity to reduce debt without foregoing any earnings should probably be taken.

Valuation-wise, prima facie, the stock looks decidedly cheap on a P/E multiple (@ 10x P/E), but the elevated levels of borrowings bloats the EV, leaving it merely mildly undervalued, I think, on an EV/EBITDA basis (@ around 6.2x) and on a Free Cash Flow yield on EV (~7.5%).

I think that - given the nature of the business and its less-than-exemplary financial pedigree - I would pay no more that 12x P/E , 7.5x EV/EBITDA, and I'd require a 10% FCF Yield.

Meaning that PRG's stock is probably 10% to 15% undervalued currently, depending on the valuation methodology one uses.

But it is not a great quality business, making it a risky investment.

And to be compensated for that elevated risk, I think one needs to be able to buy the sock at a discount of more than just 10%-or-so below fair value.

Expand

How do you compare this company to MACA. MLD.

I think MLD is probably undervalued compared to this company with less issues.

What would be your analysis comparing the two?

PRG Price at posting: $1.75 Sentiment: Buy Disclosure: Held
Upvote

0 Great analysis

Reply

Top Stories

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 8 more messages in this thread...

First 5 Last

Add PRG (ASX) to my watchlist

(20min delay)
Last $1.22		Change 0.000(0.00%)		Mkt cap ! $141.0M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
1	8771	$1.14

Sellers (Offers)

Price($)	Vol.	No.
$1.21	4	1

View Market Depth

No.	Vol.	Price($)
1	8771	1.140
1	300000	1.120
1	4700	0.950
0	0	0.000
0	0	0.000

Price($)	Vol.	No.
1.205	4	1
1.270	4846	1
1.280	5000	1
1.350	5000	1
1.400	5000	1

Last trade - 16.12pm 04/10/2024 (20 minute delay)

PRG (ASX) Chart

Day chart unavailable

New Joint Venture, page-5

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

New Joint Venture, page-5

Top Stories

BCI reaches close of funding facility for salt-first part of Mardie project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News